Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
87.5M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
40.2K
-
Shares change
-
-49.2K
-
Total reported value, excl. options
-
$577K
-
Value change
-
-$446K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$14.35
Significant Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q4 2023
3 filings reported holding KURA - Kura Oncology, Inc. - Common Stock as of Q4 2023.
Kura Oncology, Inc. - Common Stock (KURA) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.2K shares
of 87.5M outstanding shares and own 0.05% of the company stock.
Largest 10 shareholders include BVF INC/IL (7.37M shares), BlackRock Inc. (7.32M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (6.95M shares), EcoR1 Capital, LLC (5.81M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (5.31M shares), VANGUARD GROUP INC (4.04M shares), Avoro Capital Advisors LLC (2.98M shares), STATE STREET CORP (2.92M shares), Holocene Advisors, LP (2.44M shares), and ARMISTICE CAPITAL, LLC (2.22M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.